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Metabolic syndrome is a disorder characterized by having three or more of several cardiometabolic 
risk factors, including abnormal blood lipid levels, central obesity, high blood glucose levels, and high 
blood pressure.  Importantly, any particular case of metabolic syndrome may be comprised of 
different combinations of these components.  This variability in composition has made it difficult to 
determine the genetic underpinnings of the overall disorder, since genetic variants may be 
associated with individual components in different ways.  A new meta-analysis method called 
ASSET, however, provides a more powerful approach for investigating genetic variants with 
pleiotropic effects.  In a recent report inCirculation: Cardiovascular Genetics, Drs. Cara Carty and 
Charles Kooperberg and colleagues in the Public Health Sciences Division utilized this approach to 
identify several variants associated with metabolic syndrome, one of which may be specific to 
African American ancestry. 
One of the primary challenges in studying the genetic architecture of metabolic syndrome is its multi -
component definition.  While identifying whether a genetic variant is associated with any particular 
individual component is fairly straightforward, identifying how a genetic variant contributes to 
metabolic syndrome overall is more complicated.  Said senior author Dr. Kooperberg, "typically in 
genetic association studies, when we examine multiple traits, those are combined with a standard 
meta-analysis, which assumes that the genetic variant affects each trait in the same way."  In the 
case of metabolic syndrome, however, a variant may be associated with one or more components 
but not others (such as being associated with higher blood glucose and triglyceride levels but not 
with other components), or may be associated with different components in opposing directions 
(such as with higher HDL levels but smaller waist circumference).  As such, combining these 
multiple associations across components using traditional methods may not accurately capture the 
overall effect of a given variant (see figure).   
Instead, said lead author Dr. Carty, "we applied a new method, ASSET (ASsociation analysis of 
subSETs), that efficiently addresses some of the analytical issues that may arise in the investigation 
of pleiotropy."  This method detects positive and negative associations for components separately, 
and then combines these tests while accounting for the correlations among the components.  Said 
Kooperberg, "this method, developed by our colleagues Sam Bhattacharjee and Nilanjan Chatterjee 
at the National Cancer Institute, allows those traits to be divided into three groups (positive, 
negative, and null associations with a genetic variant) while maintaining the proper characteristics of 
statistical testing (especially the false positive rate)." 
The authors used the ASSET approach to test nearly 200,000 genetic variants on the Metabochip, a 
customized genotyping array targeting genomic regions associated with metabolic traits, for an 
association with metabolic syndrome or one of its components.  These variants were first tested in 
15,000 African Americans from the Population Architecture using Genomics and Epidemiology  
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(PAGE) study.  Said Kooperberg, "this metabochip data and a novel use of the ASSET methodology 
allowed us to identify 27 single nucleotide polymorphisms that were associated with some of the 
components of metabolic syndrome."  
These 27 variants were located in 5 genetic regions previously associated with glucose (TCF7L2) or 
lipid levels (LPL, APOA5,CETP, and APOC1/APOE/TOMM40).  Many of these genetic variants 
showed pleiotropic relationships in opposing directions for different components of metabolic 
syndrome.  One associated variant appeared to be an African specific variant (rs12721054 
inAPOC1), as it is found in very low frequency in other populations.  This and another variant, 
rs10096633 in LPL, demonstrated pleiotropic relationships with at least three metabolic syndrome 
components.  Of these 27 initial findings, 17 variants in three loci (LPL, APOA5, and CETP) also 
showed a statistically significant association with metabolic syndrome when tested in an 
independent replication population of roughly 5000 Hispanics.  
Overall, these results highlight the usefulness of the ASSET method for increasing statistical power 
to detect associations in cases where genetic variants may have pleiotropic relationships.  Said lead 
author Dr. Carty, "investigation of pleiotropy is an exciting area of research, particularly due to the 
wealth of genetic information now available to researchers and the potential clinical applications of 
such gene targets."  The authors hope that identifying these pleiotropic associations could eventually 
be clinically important, helping to elucidate potential gene targets for medications and contribute to 
risk profiling. 
Other PHS investigators contributing to this project were Drs. Christopher Carlson and Ulrike Peters, 
as well as Mr. Jeffrey Haessler. 
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Image provided by Dr. Cara Carty 
Association of rs247616 G allele (in CETP) with metabolic 
syndrome or its components, as assessed by different 
methods: A) association with metabolic syndrome overall 
(yes/no); B) association with each metabolic syndrome 
component individually; C) association with metabolic 
syndrome, using standard meta-analysis across the 
individual components; and D) association with metabolic 
syndrome using ASSET, overall and separated into positive 
and negative components. As ASSET takes the opposite 
directions of effect into account, a lower overall p-value of 
1.2e-20 is observed. The other methods provide p-values for 
the overall association that are attenuated (p=0.026 and 
p=0.028) due to the null effects of the other components and 
the effects in opposite directions. 
 
